{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:28:39Z","timestamp":1774862919406,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/01\/CDE\/08\/07"],"award-info":[{"award-number":["BT\/01\/CDE\/08\/07"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013999","name":"Garfield Weston Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cjca.2015.09.022","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T03:39:37Z","timestamp":1445744377000},"page":"1008.e1-1008.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits"],"prefix":"10.1016","volume":"32","author":[{"given":"Sheena","family":"Philip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiruvelselvan","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi Narasimha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suryakant","family":"Biradar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vrushali","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay V.","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi A.","family":"Mundkur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2015.09.022_bib1","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.106.615609","article-title":"Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis","volume":"114","author":"van Puijvelde","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.09.022_bib2","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/ATVBAHA.107.151274","article-title":"Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis","volume":"27","author":"van Puijvelde","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2015.09.022_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cardiores.2004.01.028","article-title":"Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I","volume":"62","author":"George","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2015.09.022_bib4","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/ATVBAHA.109.202671","article-title":"Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis","volume":"30","author":"Klingenberg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2015.09.022_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.atherosclerosis.2010.06.007","article-title":"Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her\/J mice","volume":"212","author":"Lu","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2015.09.022_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijcard.2014.06.001","article-title":"Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice","volume":"175","author":"Mundkur","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2015.09.022_bib7","first-page":"2358","article-title":"Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice","volume":"32","author":"Lu","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2015.09.022_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0163-7258(03)00069-X","article-title":"Transgenic rabbits as therapeutic protein bioreactors and human disease models","volume":"99","author":"Fan","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cjca.2015.09.022_bib9","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000028465.52694.9B","article-title":"Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma","volume":"106","author":"Aikawa","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.09.022_bib10","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0735-1097(98)00487-2","article-title":"HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis","volume":"32","author":"Bustos","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2015.09.022_bib11","doi-asserted-by":"crossref","first-page":"e58364","DOI":"10.1371\/journal.pone.0058364","article-title":"Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)\/J mice","volume":"8","author":"Mundkur","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2015.09.022_bib12","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.1128\/JVI.00294-07","article-title":"Functional Foxp3+ CD4+ CD25(Bright+) \u201cnatural\u201d regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection","volume":"81","author":"Nesburn","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cjca.2015.09.022_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-3083.2010.02414.x","article-title":"An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells","volume":"72","author":"Boks","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cjca.2015.09.022_bib14","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","article-title":"A\u00a0functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cjca.2015.09.022_bib15","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1084\/jem.20070602","article-title":"Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid","volume":"204","author":"Sun","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cjca.2015.09.022_bib16","doi-asserted-by":"crossref","first-page":"e107492","DOI":"10.1371\/journal.pone.0107492","article-title":"Peyer's patches and mesenteric lymph nodes cooperatively promote enteropathy in a mouse model of food allergy","volume":"9","author":"Nakajima-Adachi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2015.09.022_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/cimm.1995.1098","article-title":"Antigen-induced arthritis in rats is suppressed by the inducing antigen administered orally before, but not after immunization","volume":"163","author":"Yoshino","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.cjca.2015.09.022_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/clin.1998.4592","article-title":"Oral tolerance in experimental autoimmune uveoretinitis: feeding after disease induction is less protective than prefeeding","volume":"88","author":"Torseth","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.cjca.2015.09.022_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2015.09.022_bib20","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2015.09.022_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/ATVBAHA.110.219147","article-title":"A\u00a0selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice","volume":"31","author":"Johnson","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2015.09.022_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cardiores.2006.05.009","article-title":"Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability","volume":"71","author":"Johnson","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2015.09.022_bib23","doi-asserted-by":"crossref","first-page":"e66754","DOI":"10.1371\/journal.pone.0066754","article-title":"Gene deficiency in activating Fc\u03b3 receptors influences the macrophage phenotypic balance and reduces atherosclerosis in mice","volume":"8","author":"Mallavia","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2015.09.022_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/cvr\/cvr057","article-title":"Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I","volume":"91","author":"Reimers","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2015.09.022_bib25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.3316","article-title":"Proliferating macrophages prevail in atherosclerosis","volume":"19","author":"Randolph","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2015.09.022_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cjca.2015.09.022_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","article-title":"Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques","volume":"117","author":"Tacke","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2015.09.022_bib28","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1161\/ATVBAHA.110.210492","article-title":"CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells","volume":"30","author":"He","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2015.09.022_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1172\/JCI64617","article-title":"Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs","volume":"123","author":"Subramanian","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cjca.2015.09.022_bib30","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.108.806158","article-title":"Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage","volume":"119","author":"Gautier","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2015.09.022_bib31","first-page":"367","article-title":"Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability","volume":"149","author":"Bjorkerud","year":"1996","journal-title":"Am J Pathol"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2015.09.022_bib32","first-page":"E40","article-title":"Macrophage apoptosis in advanced atherosclerosis","volume":"1173","author":"Tabas","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cjca.2015.09.022_bib33","doi-asserted-by":"crossref","first-page":"e0123393","DOI":"10.1371\/journal.pone.0123393","article-title":"Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)\/J mice","volume":"10","author":"Xia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2015.09.022_bib34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1160\/TH06-07-0395","article-title":"Integrin binding characteristics of the disintegrin-like domain of ADAM-15","volume":"96","author":"Lu","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2015.09.022_bib35","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.109.863431","article-title":"Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice","volume":"20","author":"Sasaki","year":"2009","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X15014919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X15014919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:44:14Z","timestamp":1774860254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X15014919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0828282X15014919"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2015.09.022","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2015.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}